About Us
  Join the Mailing List



Exhibit Opportunities


Hotel Accommodation

Invitation/Visa Information

Conference Handbook


GeneExpression Systems, Inc & Appasani Research Conferences and Educational Institue (ARCEI.ORG)
Jointly Presents

First International: Therapeutics Discovery Symposium Asia
Small RNAs to Stem Cells & Epigenetic Reprogramming Asia-2013 Meeting
‘RNA Regulation to Delivery, Programming to Pluripotency & Therapeutics’

Date: November 25 – 26, 2013

Venue: Sanjo Conference Hall, University of Tokyo Hongo Campus, Tokyo, JAPAN

Why do you wait to join for an intellectual gathering in the ‘Small RNAs & Stem Cell Science’ arena at the prestigious Japanese University campus!

Click Here For Brochure

Small RNAs to Stem Cells & Epigenetic Reprogramming Asia-2013 is our first meeting in our ‘Therapeutics Discovery Symposium Asia Series,’ and Second International Meeting on this related topic. The first was held at Embassy Suites, Burlingame-San Francisco, California, USA on December 5-6, 2009, which was inaugurated by UCSF Professor Dr. Deepak Srivastava. The purpose and scope of this symposium is to provide a forum for the discussion of the current state of the art of rapidly evolving and inter-related RNA biology, Stem Cell Biology and Epigenomics fields. These have attracted a much attention in recent years from both academic and industry laboratories, so we combined and grouped into ‘Small RNAs to Stem Cells & Epigenetic Reprogramming.’

In this international meeting, prominent researchers (Developmental biologists, cell biologists, molecular biologists, computational biologists, neurobiologists, clinicians, chemists and physicists)  from both academia and industry will gather and discuss the applications in form of keynote lectures, invited talks, short oral, and poster presentations. All the members (except keynote speakers) who participate in this symposium have to register for the meeting by paying the appropriate registration fee. This meeting is for PhD students and professors from academia, R&D scientists, executives from biotech and pharmaceutical industry.

Venue: Sanjo Conference Hall, which is the state of art meeting facility located in the University of Tokyo campus, Tokyo, Japan. Nearby nice and comfortable hotel, information is given in the accommodation page of this meeting. Please join for an intellectual gathering in the Small RNAs to Stem Cells & Epigenetic Reprogramming’ arena in the electronic city of the world, Tokyo, Japan.

Unique Global Event in Combining Small RNAs Biology with Reprogramming Biology & Epigenetics

Meet Experts From: World Premier International Research Universities/Institutes/Companies



Expected Maximum Capacity:
Target Audience 150
Total Speaker Presentations: 30
Total Poster Presentations: 10
Total Exhibit Booths: 10

Monday, Novermber 25, 2013
8:30 A.M: Registration Open
9.00 AM – 6.00 PM Scientific Sessions

Tuesday, November 26, 2013
8:30 A.M: Registration Open
9.00 AM – 6.00 PM Scientific Sessions

Click Here For Agenda

Scientific Organizer:
Krishnarao APPASANI, PhD., MBA
Founder & CEO
GeneExpression Systems, Inc
Waltham, MA USA

Scientific Committee:

Nagy Habib, MB Ch, PhD, FRCS, UK
Kumiko Saeki, MD, PhD. Japan

Key Sessions:
  • The Biology of RNA, microRNAs & Non-coding RNAs
  • RNAi/miRNAs/Oligo Drug targets & Delivery in vivo
  • Disease Biology of small RNAs
  • Chromatin Biology & Nuclear dynamics
  • Epigenetic programming in stem cells
  • Pluripotency &Transcriptional Controls of Stem Cells
  • Direct reprogramming to Somatic cloning
  • High throughput screenings & Sequencing technology
  • Development of RNA & Epigenetics-based Therapeutics
  • Novel Reagents & Applications of Reprogramming & RNAi Technology
  • Applications of induced Pluripotent Stem Cells & Cell Therapy

Keynote Speakers:

Hideyuki OKANO, MD, PhD.
P rofessor of Physiology &
Chairman of Graduate School of Medicine
Keio University School of Medicine
Tokyo, Japan
Title: Post-transcriptional regulation of stem cell properties
Shunsuke ISHII, PhD.         
Chief Scientist
RIKEN Tsukuba Institute
Tsukuba, Ibaraki, Japan
Title: Inheritance of stress-induced epigenome changes

Other Speakers:

Professor of Surgery
Imperial College of London
Hammersmith Hospital, London, UK
Title: Differentiation of CD34+ cells using small activating RNA targeting the Islet β-cell transcriptional
factor MafA
Kenzaburo TANI, MD, PhD.
Professor of Medical Genomics
Medical Institute of Bioregulation
Kyushu University Hospital
Fukuoka, Japan
Title: MicroRNA-targeted coxsackievirus B3 infection markedly reduces its toxicity without losing its original oncolytic activity
Piero CARNINCI, PhD.                                            
Director of the Division of Genomic Technologies
Yokohama, Kanagawa, JAPAN
Title: Identification of novel long-non-coding RNAs that are important for maintenance of iPS
Yangming WANG, PhD.                                          
Professor of Molecular Medicine &
PI, Lab. of Stem Cells and Noncoding RNAs
Peking University
Beijing, PR. China
Title: MicroRNA regulation of cell cycle and self-renewal in embryonic stem cells
Matthew HSU, PhD.
Director of R&D-Bioscience Division
Merck Millipore, Inc.
Temecula, California, USA
Title: miRNA profiling of cancer cells using SmartFlareTM, a novel live-cell RNA detection technology
Kumiko SAEKI, MD, PhD.
Director of the Division of Stem Cell Therapy
Research Institute
National Center for Global Health & Medicine
Tokyo, Japan
Title: Production of functional brown adipocytes from human pluripotent stem cells
Hiroshi SUZUKI, MD. 
Molecular Pathology
University of Tokyo
Tokyo, Japan
Title: Understanding RNA language for the future nucleic acid medicine
Hironori WAKI, MD, PhD.                                       
Project Associate Professor
Graduate School of Medicine-University of Tokyo
Tokyo, Japan
Title: Genome-wide profiling of brown fat-specific open regulatory regions tdentifies NFIA as a transcriptional regulator of brown fat–muscle cell lineage specification
Toru NAKANO, MD, PhD.                          
Professor of Pathology
Graduate School of Frontier Biosciences
Osaka University School of Medicine
Suita, Osaka, JAPAN
Title: Artificial induction of germ cell specific gene silencing through piRNA pathway
Yota MURAKAMI, PhD.                                          
Professor of Chemistry
Hokkaido University
Sapporo, Hokkaido, Japan
Title: Noncoding RNAs & RNAi-directed heterochromatin formation
Noemi FUSAKI, PhD.                        
Team Leader-JST PRESTO
Keio University School of Medicine
Tokyo, Japan
Title: Efficient generation of integration-free patient-specific pluripotent stem cells and drug screening
  Yu Fujita, MD. 
Research Associate in Respiratory Diseases
Jikei University School of Medicine &
Division of Molecular and Cellular Medicine
National Cancer Center Research Institute
Tokyo, Japan
Title: A novel microRNA-mediated regulation of lung cancer stem cells
Hidetoshi TAHARA, PhD.
Professor of Cellular & Mol. Biology
Hiroshima University
Hiroshima, Japan
Title: Therapeutic role of microRNAs in cancer and cellular senescence
Kuniaki SAITO, PhD.
Associate Professor of Molecular Biology
Keio University School of Medicine
Tokyo, Japan
Title: piRNA pathway in Drosophila
Sun LEI, PhD.
Assistant Professor
Duke-NUS Graduate Medical School
Title: Title: long non-coding RNA in adipocyte development
Principle Investigator
Neural Stem Cell Research Lab
National Neuroscience Institute, Singapore
Title: Amyloid Precursor Protein (APP) regulates the proliferation and differentiation of neural progenitors by antagonising miRNA in the developing cerebral cortex
Co-founder of TranSINE Technologies Co. Ltd.
RIKEN Yokohama Institute, Japan &
Associate Professor of Neurobiology
International School for Advanced Studies, Trieste, Italy
Title: SINEUPs: a new functional class of natural and synthetic antisense non-coding RNAs that activate translation
Chanil Chang                                                           
Director of R&D institute
BioMolecular Therapeutics, Inc.
Seoul, Korea
Title: Anti-Scar therapeutics development using cell-penetrating asymmetric RNAi triggers
Hideo AKIYAMA, PhD.                                            
Deputy General Manager
New Projects Development Division
Toray Industries, Inc.
Kamakura, Kanagawa, JAPAN
Blood miRNA as a cancer biomarker
Akihiko OKUDA, MD., PhD.
Professor & Chair of Developmental Biology
Research Center for Genomic Medicine
Saitama Medical University
Hidaka, Saitama, Japan
Underlying the molecular bases of cell death phenotype of Max-null embryonic stem cells
Professor & Chair of Stem Cell Biology
Tohoku University School of Medicine
Sendai, Japan
Title: Discovery of intrinsic pluripotent stem cells, Muse cells, that resides in adult human mesenchymal tissues
Hodaka FUJII, MD, PhD.
Associate Professor
Osaka University
Suita-shi, Osaka, Japan
Title: Locus-specific biochemical analysis of genome functions by iChIP and enChIP
Ryuichi ONO, PhD.                                                  
Assistant Professor of Epigenetics
Tokyo Medical & Dental University
Bunkyo-ku, Tokyo, Japan
Title: Evolution of mammalian viviparity by retrotransposon-derived imprinted genes
Makoto INAKI, PhD.                                                
Researcher in Genetics
National Research Institute for Child Health and Development
Setagaya-ku, Tokyo, Japan
Title: Primary human B lymphocyte-derived iPS cells, their generation and application
Takashi SONOKI, MD, PhD.
Associate Professor of Hematology/Oncology
Wakayama Medical University
Wakayama, Japan Title: MiR125 is an oncomir in both myeloid or lymphoid tumors as shown mouse models
  Timothy LEE
BioSpherix, Ltd.
Lacona, New York, USA
Title: Better manufacturing practice for cell therapies
Takanori TAKEBE, MD.
Assistant Professor in Regenerative Medicine 
Yokohama City University School of Medicine
Kanazawa-ku, Yokohama, Japan 
Title: Vascularized and functional human liver from an iPSC-derived organ bud transplant
Yasuo OUCHI, PhD.
Assistant Professor of Biomedical Sciences
Chubu University
Kasugai, Aichi, Japan
Title: The emerging role of microRNA biogenesis in adult neurogenesis and schizophrenia

* Presenting Speaker names, title and times are subject to change.
Host organization, organizer, or scientific committee does not take any kind of responsibility.

Exhibitors are welcome to reserve their booth space early!

Please contact if you are interested in Presenting the Poster in this meeting.

GeneExpression Systems, Inc.
P.O. Box 540170
Waltham, MA 02454 USA
Tel: (781) 891-8181
Fax: (781)730-0700 or (781) 891-8234
E-mail: Genexpsys@expressgenes.com

Note: Speakers Names, Titles and venue subjected to change beyond our control for which the company is not responsible.

Oral Presentation Abstract Submission by September 30, 2013
Poster Abstract Submission by November 10, 2013

Email your abstract (100-200 words in word format) to: genexpsys@expressgenes.com

GeneExpression Systems™ All Rights Reserved 2013